Literature DB >> 8425611

FVIIa derivatives obtained by autolytic and controlled cathepsin G mediated cleavage.

E M Nicolaisen1, L Thim, J K Jacobsen, P F Nielsen, I Mollerup, T Jørgensen, U Hedner.   

Abstract

The heavy chain of coagulation factor VII contains a serine esterase entity. A partial cleavage in the heavy chain occurs during purification and activation of the single-chain zymogen, presumably as a result of autolysis. Neutrophil cathepsin G initially generates a Gla-domainless FVIIa without coagulant activity. However, on extended exposure cleavage also occurs in the heavy chain, resulting in a complete loss of enzyme activity. Four cleavage sites on the heavy chain, two susceptible to trypsin-like autolysis and two susceptible to chymotrypsin-like cathepsin G-mediated catalysis have been identified. The hydrolysis of peptide bonds in the heavy chain might contribute to regulation of the coagulation process in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425611     DOI: 10.1016/0014-5793(93)81285-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo.

Authors:  Paris Margaritis; Elise Roy; Armida Faella; Harre D Downey; Lacramioara Ivanciu; Giulia Pavani; Shangzhen Zhou; Ralph M Bunte; Katherine A High
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

2.  A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.

Authors:  Raffaella Toso; Mirko Pinotti; Katherine A High; Eleanor S Pollak; Francesco Bernardi
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

3.  Successful treatment of canine hemophilia by continuous expression of canine FVIIa.

Authors:  Paris Margaritis; Elise Roy; Majed N Aljamali; Harre D Downey; Urs Giger; Shangzhen Zhou; Elizabeth Merricks; Aaron Dillow; Mirella Ezban; Timothy C Nichols; Katherine A High
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

4.  Mass spectrometric characterization of N- and O-glycans of plasma-derived coagulation factor VII.

Authors:  François Fenaille; Catherine Groseil; Christine Ramon; Sandrine Riandé; Laurent Siret; Sami Chtourou; Nicolas Bihoreau
Journal:  Glycoconj J       Date:  2008-07-20       Impact factor: 2.916

5.  Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor.

Authors:  Tanusree Sengupta; Tilen Koklic; Barry R Lentz; Rinku Majumder
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.